ArticleAnnals of translational medicine2020

Novel tumor mutation score versus tumor mutation burden in predicting survival after immunotherapy in pan-cancer patients from the MSK-IMPACT cohort.

Yuan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.